Vivos Therapeutics (VVOS) Current Deferred Revenue (2019 - 2026)
Vivos Therapeutics (VVOS) reported Current Deferred Revenue of $495000.0 for Q1 2026, down 16.67% year-over-year from $594000.0 in Q1 2025, and up 3.34% on a QoQ basis from $479000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Current Deferred Revenue data on file, last reported at $495000.0 in Q1 2026.
- Quarterly Current Deferred Revenue fell 16.67% year-over-year to $495000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $495000.0 (down 16.67% YoY) and the FY2025 annual result came in at $479000.0, down 51.76% from the prior year.
- Current Deferred Revenue rose to $495000.0 in Q1 2026 per VVOS's latest filing, from $479000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.0 million in Q4 2022 and bottomed at $479000.0 in Q4 2025.
- The 5-year median for Current Deferred Revenue is $2.2 million (2022), against an average of $1.8 million.
- The widest annual swing landed in 2023, when Current Deferred Revenue jumped 34.06%; it then sank 79.73% in 2025.
- Tracing VVOS's Current Deferred Revenue over 5 years: stood at $3.0 million in 2022, then retreated by 20.11% to $2.4 million in 2023, then plunged by 59.09% to $993000.0 in 2024, then slumped by 51.76% to $479000.0 in 2025, then rose by 3.34% to $495000.0 in 2026.
- Per Business Quant, the three latest VVOS Current Deferred Revenue figures stand at $495000.0 (Q1 2026), $479000.0 (Q4 2025), and $538000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 594,000.00 |
| Dec 31, 2024 | 896,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 2.90 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 3.70 Mn |
| Jun 30, 2021 | 4.12 Mn |
| Mar 31, 2021 | 2.80 Mn |
| Dec 31, 2020 | 2.94 Mn |
| Sep 30, 2020 | 3.14 Mn |
| Jun 30, 2020 | 3.04 Mn |
| Mar 31, 2020 | 2.62 Mn |
| Dec 31, 2019 | 2.95 Mn |